Effect of age and disease on bone mass in Japanese patients with schizophrenia

Annals of General Psychiatry

Volumn 11, Issue , 2012, Pages

  Sugawara, Norio ^a   Yasui Furukori, Norio ^a   Umeda, Takashi ^a   Tsuchimine, Shoko ^a   Fujii, Akira ^a   Sato, Yasushi ^a,b   Saito, Manabu ^a   Furukori, Hanako ^c   Danjo, Kazuma ^a   Matsuzaka, Masashi ^a   Takahashi, Ippei ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Hirosaki Aiseikai Hospital   (Japan)

^c Kuroishi Akebono Hospital   (Japan)

Author keywords

Bone mass; Japanese; Schizophrenia; Ultrasound

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BONE DENSITOMETRY; BONE MASS; CALCANEUS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEALTH PROMOTION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL PATIENT; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 84857136794     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-11-5     Document Type: Article

References (35)

1. Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry 2007, 190:129-134. 10.1192/bjp.bp.106.023671, 17267929.
2. Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965-84. Br J Psychiatry 1991, 159:790-794. 10.1192/bjp.159.6.790, 1790446.
3. Delva NJ, Crammer JL, Jarzylo SV, Lawson JS, Owen JA, Sribney M, Weir BJ, Yendt ER. Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol Psychiatry 1989, 26:781-793. 10.1016/0006-3223(89)90119-4, 2590692.
4. Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, Rosan R. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995, 57:485-491.
5. Abraham G, Halbreich U, Friedman RH, Josiassen RC. Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res 2003, 59:17-18. 10.1016/S0920-9964(01)00321-8, 12413637.
6. Meaney AM, Smith S, Howes OD, O'Brien M, Murray RM, O'Keane V. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br J Psychiatry 2004, 184:503-508. 10.1192/bjp.184.6.503, 15172944.
7. de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994, 35:408-419. 10.1016/0006-3223(94)90008-6, 8018788.
8. Lindholm J, Steiniche T, Rasmussen E, Thamsborg G, Nielsen IO, Brockstedt-Rasmussen H, Storm T, Hyldstrup L, Schou C. Bone disorder in men with chronic alcoholism: a reversible disease?. J Clin Endocrinol Metab 1991, 73:118-124. 10.1210/jcem-73-1-118, 2045462.
9. Ataya K, Mercado A, Kartaginer J, Abbasi A, Moghissi KS. Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil Steril 1988, 50:876-881.
10. Kishimoto T, Watanabe K, Shimada N, Makita K, Yagi G, Kashima H. Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia. J Clin Psychiatry 2008, 69:385-391. 10.4088/JCP.v69n0307, 18278991.
11. Renn JH, Yang NP, Chueh CM, Lin CY, Lan TH, Chou P. Bone mass in schizophrenia and normal populations across different decades of life. BMC Musculoskelet Disord 2009, 10:1. 10.1186/1471-2474-10-1, 2642755, 19118498.
12. Jung DU, Kelly DL, Oh MK, Kong BG, Kang JW, Lee SJ, Shim JC. Bone mineral density and osteoporosis risk in older patients with schizophrenia. J Clin Psychopharmacol 2011, 31:406-410. 10.1097/JCP.0b013e318221b123, 21694624.
13. Kang C, Speller R. Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus. Br J Radiol 1998, 71:861-867.
14. Greenspan SL, Cheng S, Miller PD, Orwoll ES. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int 2001, 12:391-398. 10.1007/s001980170108, 11444088.
15. Meszaros S, Toth E, Ferencz V, Csupor E, Hosszu E, Horvath C. Calcaneous quantitative ultrasound measurements predicts vertebral fractures in idiopathic male osteoporosis. Joint Bone Spine 2007, 74:79-84. 10.1016/j.jbspin.2006.04.008, 17197223.
16. Rey-Sánchez P, Lavado-García JM, Canal-Macías ML, Gómez-Zubeldia MA, Roncero-Martín R, Pedrera-Zamorano JD. Ultrasound bone mass in schizophrenic patients on antipsychotic therapy. Hum Psychopharmacol 2009, 24:49-54. 10.1002/hup.984, 19016257.
17. Japan Meteorological Agency Weather statistics Japan Meteorological Agency., http://www.data.jma.go.jp/obd/stats/etrn/index.php
18. Tsuda-Futami E, Hans D, Njeh CF, Fuerst T, Fan B, Li J, He YQ, Genant HK. An evaluation of a new gel-coupled ultrasound device for the quantitative assessment of bone. Br J Radiol 1999, 72:691-700.
19. Nakamura K, Nashimoto M, Tsuchiya Y, Obata A, Miyanishi K, Yamamoto M. Vitamin D insufficiency in Japanese female college students: a preliminary report. Int J Vitam Nutr Res 2001, 71:302-305. 10.1024/0300-9831.71.5.302, 11725695.
20. Sugawara N, Yasui-Furukori N, Fujii A, Saito M, Sato Y, Nakagami T, Tsuchimine S, Kaneko S. No association between bone mass and prolactin levels among patients with schizophrenia. Hum Psychopharmacol 2011, 26:596-601. 10.1002/hup.1250, 22105774.
21. Liu-Seifert H, Kinon BJ, Ahl J, Lamberson S. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann N Y Acad Sci 2004, 1032:297-298. 10.1196/annals.1314.044, 15677434.
22. Lindsay R. The effect of sex steroids on the skeleton in premenopausal women. Am J Obstet Gynecol 1992, 166:1993-1996.
23. Halbreich U, Palter S. Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 1996, 22:447-454.
24. Nilsson BM, Forslund AH, Olsson RM, Hambraeus L, Wiesel FA. Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatr Scand 2006, 114:27-35. 10.1111/j.1600-0447.2005.00700.x, 16774658.
25. Saarni SE, Saarni SI, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, Lönnqvist J. Body composition in psychotic disorders: a general population survey. Psychol Med 2009, 39:801-810. 10.1017/S0033291708004194, 18713488.
26. Baumgartner RN, Stauber PM, Koehler KM, Romero L, Garry PJ. Associations of fat and muscle masses with bone mineral in elderly men and women. Am J Clin Nutr 1996, 63:365-372.
27. Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI. Body composition changes with age have gender-specific impacts on bone mineral density. Bone 2004, 35:792-798. 10.1016/j.bone.2004.05.016, 15336618.
28. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinemia: mechanisms, clinical features and management. Drugs 2004, 64:2291-2314. 10.2165/00003495-200464200-00003, 15456328.
29. Yasui-Furukori N, Kondo T, Suzuki A, Mihara K, Kaneko S. Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia. Psychopharmacology 2002, 162:63-66. 10.1007/s00213-002-1058-6, 12107619.
30. Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA, Fleischhacker WW. Osteoporosis in patients with schizophrenia. Am J Psychiatry 2005, 162:162-167. 10.1176/appi.ajp.162.1.162, 15625215.
31. Cetin A, Erturk H, Celiker R, Sivri A, Hascelik Z. The role of quantitative ultrasound in predicting osteoporosis defined by dual X-ray absorptiometry. Rheumatol Int 2001, 20:55-59. 10.1007/PL00006857, 11269533.
32. Mulleman D, Legroux-Gerot I, Duquesnoy B, Marchandise X, Delcambre B, Cortet B. Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int 2002, 13:388-393. 10.1007/s001980200044, 12086349.
33. Dane C, Dane B, Cetin A, Erginbas M. The role of quantitative ultrasound in predicting osteoporosis defined by dual-energy X-ray absorptiometry in pre- and postmenopausal women. Climacteric 2008, 11:296-303. 10.1080/13697130802178471, 18645695.
34. Herd RJ, Blake GM, Miller CG, Parker JC, Fogelman I. The ultrasonic assessment of osteopenia as defined by dual X-ray absorptiometry. Br J Radiol 1994, 67:631-635. 10.1259/0007-1285-67-799-631, 8061996.
35. Frost ML, Blake GM, Fogelman I. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip. Calcif Tissue Int 2002, 71:207-211. 10.1007/s00223-001-2074-y, 12154392.